BiotechTube
Home/Nova Eye Medical/Kate Hunt
KH

Kate Hunt

Chief Commercial Officer

Nova Eye Medical

Therapeutic Areas

OphthalmologyGlaucoma

Nova Eye Medical Pipeline

DrugIndicationPhase
iTrack™ AdvanceOpen‑angle glaucomaFDA 510(k) cleared
iTrack™Open‑angle glaucoma (viscodilation)CE Marked
Molteno3®Complex glaucomaCommercial

Leadership Team at Nova Eye Medical

TS
Tom Spurling
Chief Executive Officer
JB
Joe Bankovich
President, Global Sales
View full Nova Eye Medical profile